FTC targets POM Wonderful juice ads

09/29/2010 06:16:20 PM
Mike Hornick

POM Wonderful said it’s spent $34 million on pomegranate research over more than a decade. More than 55 studies on POM products, including 19 clinical trials, have been published in peer reviewed journals, according to the company.

In a related case, Mark Dreher, POM Wonderful’s former head of scientific and regulatory affairs, has agreed to a settlement that bars him from making disease treatment or prevention claims in ads for company products unless they meet FDA requirements.

Prev 1 2 Next All

Comments (0) Leave a comment 

e-Mail (required)


characters left

Join the conversation - sign up for FREE today!
Feedback Form
Leads to Insight